Table 4. Impact of enrollment on trials on event-free and overall survival in adjusted modelsa.
Event-free survival |
Overall survival |
|||
---|---|---|---|---|
Characteristics | HR (95% CI) | P-value | HR (95% CI) | P-value |
Variables included in multiple regression | ||||
Demographic: age, gender, ethnicity, era | 0.60 (0.48–0.76) | <0.0001 | 0.61 (0.45–0.82) | 0.001 |
Leukaemia: white count, CNS status, immunophenotype, cytogenetics | 0.72 (0.53–0.99) | 0.040 | 0.75 (0.50–1.13) | 0.163 |
Socioeconomic: distance and income quintile | 0.64 (0.50–0.82) | 0.0003 | 0.63 (0.45–0.86) | 0.004 |
Demographic, leukaemic and socioeconomic factors | 0.67 (0.47–0.95) | 0.023 | 0.69 (0.44–1.08) | 0.102 |
Abbreviations: CI=confidence interval; CNS=central nervous system; HR=hazard ratio.
Multiple Cox proportional hazards model in which the estimates reflect the adjusted effect of enrollment on trials where a HR<1 indicates better survival.